Survey Dispels Myths About Growing Dual-Earner Market von Pralle, Michael E

Volltext

Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia von Schlenk, Richard F, Döhner, Konstanze, Döhner, Hartmut, Krauter, Jürgen, Fröhling, Stefan, Corbacioglu, Andrea, Bullinger, Lars, Habdank, Marianne, Späth, Daniela, Morgan, Michael, Benner, Axel, Schlegelberger, Brigitte, Heil, Gerhard, Ganser, Arnold

Volltext

Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B von Schlenk, Richard F, Dohner, Konstanze, Kneba, Michael, Gotze, Katharina, Hartmann, Frank, del Valle, Francesco, Kirchen, Heinz, Koller, Elisabeth, Fischer, Jorg T, Bullinger, Lars, Habdank, Marianne, Spath, Daniela, Groner, Silja, Krebs, Bernhard, Kayser, Sabine, Corbacioglu, Andrea, Anhalt, Andreas, Benner, Axel, Frohling, Stefan, Dohner, Hartmut, German-Austrian AML Study Group (AMLSG)

Volltext

Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia von Hehlmann, Rüdiger, Berger, Ute, Pfirrmann, Markus, Heimpel, Hermann, Hochhaus, Andreas, Hasford, Joerg, Kolb, Hans-Jochem, Lahaye, Tanja, Maywald, Ole, Reiter, Andreas, Hossfeld, Dieter K., Huber, Christoph, Löffler, Helmut, Pralle, Hans, Queisser, Wolfgang, Tobler, Andreas, Nerl, Christoph, Solenthaler, Max, Goebeler, Mariele E., Griesshammer, Martin, Fischer, Thomas, Kremers, Stephan, Eimermacher, Hartmut, Pfreundschuh, Michael, Hirschmann, Wolf-Dietrich, Lechner, Klaus, Wassmann, Barbara, Falge, Christiane, Kirchner, Hartmut H., Gratwohl, Alois

Volltext

Prediction of Molecular Response of Chronic Phase CML Patients by the EUTOS Score: Results of the Randomized CML-Study IV von Saussele, Susanne, Lauseker, Michael, Hoffmann, Verena, Proetel, Ulrike, Hanfstein, Benjamin, Baerlocher, Gabriela M., Heim, Dominik, Ehninger, Gerhard, Hossfeld, Dieter K., Kolb, Hans-Jochem, Krause, Stefan W., Nerl, Christoph, Pralle, Hans, Schubert, Joerg E.A., Einsele, Hermann, Hänel, Matthias, Ho, Anthony D., Falge, Christiane, Kanz, Lothar, Neubauer, Andreas, Kneba, Michael, Stegelmann, Frank, Pfreundschuh, Michael, Waller, Cornelius F., Spiekermann, Karsten, Schnittger, Susanne, Pfirrmann, Markus, Hochhaus, Andreas, Hasford, Jörg, Hehlmann, Rüdiger, Müller, Martin C

Volltext

Second Line Therapy with Second Generation TKI After Intolerance to Imatinib Based Treatments Showed High Overall Survival in Contrast to Second Line Therapy After Resistance; Resu... von Saussele, Susanne, Lauseker, Michael, Proetel, Ulrike, Müller, Martin C., Hanfstein, Benjamin, Schreiber, Annette, Nolte, Florian, Baerlocher, Gabriela M., Ehninger, Gerhard, Heim, Dominik, Hossfeld, Dieter K., Krause, Stefan W., Nerl, Christoph, Pralle, Hans, Schubert, Joerg E.A., Einsele, Hermann, Hänel, Matthias, Ho, Anthony D., Falge, Christiane, Kanz, Lothar, Neubauer, Andreas, Kneba, Michael, Stegelmann, Frank, Pfreundschuh, Michael, Waller, Cornelius F., Spiekermann, Karsten, Hofmann, Wolf Karsten, Hasford, Jörg, Pfirrmann, Markus, Hochhaus, Andreas, Hehlmann, Rüdiger

Volltext

Randomized Comparison of Imatinib 800 Mg Vs. Imatinib 400 Mg +/- IFN in Newly Diagnosed BCR/ABL Positive Chronic Phase CML: Analysis of Molecular Remission at 12 Months; The German... von Hehlmann, Rudiger, Jung-Munkwitz, Susanne, Lauseker, Michael, Leitner, Armin, Pletsch, Nadine, Shazi, Samina, Müller, Martin C., Haferlach, Claudia, Schlegelberger, Brigitte, Schnittger, Susanne, Waller, Cornelius F., Neubauer, Andreas, Kanz, Lothar, Hänel, Mathias, Mayer, Jiri, Stegelmann, Frank, Fuchs, Roland, Berdel, Wolfgang E., Balleisen, Leopold, Pfirrmann, Markus, Ehninger, Gerhard, Fischer, Thomas, Hossfeld, Dieter K., Kolb, Hans- Jochem, Krause, Stefan W., Nerl, Christoph, Pralle, Hans, Gratwohl, Alois, Tobler, Andreas, Heimpel, Hermann, Hasford, Joerg, Hochhaus, Andreas, Saussele, Susanne, The German CML Study Group

Volltext

Optimaization of Imatinib Therapy by Combination. 5 Year Survival and Response Results of the Pilot Phase of the Randomized German CML STUDY IV von Pletsch, Nadine, Saussele, Susanne, Lauseker, Michael, Leitner, Armin, Jung-Munkwitz, Susanne, Shazi, Samina, Haferlach, Claudia, Schlegelberger, Brigitte, Müller, Martin C, Schenk, Thomas, Schnittger, Susanne, Pfirrmann, Markus, Ehninger, Gerhard, Fischer, Thomas, Hossfeld, Dieter K., Kolb, Hans-Jochem, Krause, Stefan W, Nerl, Christoph, Pralle, Hans, Gratwohl, Alois, Tobler, Andreas, Heimpel, Hermann, Balleisen, Leopold, Einsele, Hermann, Ho, Anthony D., Falge, Christine, Hänel, Mathias, Pfreundschuh, Michael, Kanz, Lothar, Stegelmann, Frank, Köhne, Claus-Henning, Kremers, Stephan, Spiekermann, Karsten, Berdel, Wolfgang E, Waller, Cornelius F., Bentz, Martin, Hasford, Joerg, Hochhaus, Andreas, Hehlmann, Rüdiger, The German CML Study Group

Volltext

Dmg treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. Commentary von GUILHOT, Francois, HEHLMANN, Rüdiger, REITER, Andreas, HOSSFELD, Dieter K, HUBER, Christoph, LÖFFLER, Helmut, PRALLE, Hans, QUEISSER, Wolfgang, TOBLER, Andreas, NERL, Christoph, SOLENTHALER, Max, GOEBELER, Mariele E, BERGER, Ute, GRIESSHAMMER, Martin, FISCHER, Thomas, KREMERS, Stephan, EIMERMACHER, Hartmut, PFREUNDSCHUH, Michael, HIRSCHMANN, Wolf-Dietrich, LECHNER, Klaus, WASSMANN, Barbara, FALGE, Christiane, KIRCHNER, Hartmut H, PTIRRMANN, Markus, GRATWOHL, Alois, HEIMPEL, Hermann, HOCHHAUS, Andreas, HASFORD, Joerg, KOLB, Hans-Jochem, LAHAYE, Tanja, MAYWALD, Ole

Volltext